TARGETED DELIVERY OF OXALIPLATIN VIA FOLATE-DECORATED NIOSOMAL NANOPARTICLES POTENTIATES RESISTANCE REVERSION OF COLON CANCER CELLS

Targeted delivery of oxaliplatin via folate-decorated niosomal nanoparticles potentiates resistance reversion of colon cancer cells

Background: Colorectal cancer (CRC) is a prevalent type of cancer, ranking third in incidence and fourth in cancer-related deaths globally.The increase in mortality rates related to colorectal cancer among younger patients is a cause for concern.Chemotherapy is the primary People Art approach for palliative care in colon cancer, but the development

read more